Green Planet Bio Engineering Co. Ltd. SEC filings GPLB
Green Planet Bio Engineering Co. Ltd. has 154 filings in SEC EDGAR's recent list, going back to May 2, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on May 15, 2025 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Auditor change
|
Oct 14, 2022 | Oct 11, 2022 |
| 8-K |
Current report
Auditor change
|
Dec 23, 2019 | Dec 18, 2019 |
| 8-K/A |
Amended current report
Auditor change
|
May 8, 2012 | May 8, 2012 |
| 8-K/A |
Amended current report
Auditor change
|
May 3, 2012 | May 2, 2012 |
| 8-K |
Current report
Auditor change
|
Apr 23, 2012 | Apr 23, 2012 |
| 8-K |
Current report
Change in control, Officer or director change
|
Mar 23, 2012 | Mar 2, 2012 |
| 8-K/A |
Amended current report
Auditor change
|
Dec 2, 2011 | Nov 18, 2011 |
| 8-K |
Current report
Auditor change
|
Nov 22, 2011 | Nov 18, 2011 |
| 8-K |
Current report
Other events
|
Feb 4, 2011 | Dec 20, 2010 |
| 8-K |
Current report
Other events
|
Apr 19, 2010 | Apr 14, 2010 |
| 8-K/A |
Amended current report
Auditor change
|
Feb 5, 2010 | Jan 18, 2010 |
| 8-K |
Current report
Auditor change
|
Jan 25, 2010 | Jan 18, 2010 |
| 8-K |
Current report
New debt
|
Sep 2, 2009 | Aug 31, 2009 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 27, 2009 | Jul 22, 2009 |
| 8-K/A |
Amended current report
Auditor change
|
Jan 9, 2009 | Dec 31, 2008 |
| 8-K |
Current report
Auditor change
|
Jan 7, 2009 | Dec 31, 2008 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change
|
Nov 24, 2008 | Oct 24, 2008 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change
|
Oct 29, 2008 | Oct 24, 2008 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Bylaw or fiscal year change
|
Oct 6, 2008 | Sep 30, 2008 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GPLB (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Aventura, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1392449
- Former names
- Mondo Acquisition II, Inc. (until Oct 9, 2008)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.